# Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

> **NCT01399255** · PHASE1 · WITHDRAWN · sponsor: **Wockhardt**

## Conditions studied

- Bioequivalence in Healthy Subjects

## Interventions

- **BIOLOGICAL:** Insulin lispro

## Key facts

- **NCT ID:** NCT01399255
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-11
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was not initiated
- **Last updated:** 2013-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399255, "Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01399255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*